Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04027309
Title A Study of Gilteritinib Versus Midostaurin in Combination With Induction and Consolidation Therapy Followed by One-year Maintenance in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndromes With Excess Blasts-2 With FLT3 Mutations Eligible for Intensive Chemotherapy (HOVON 156 AML)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Stichting Hemato-Oncologie voor Volwassenen Nederland
Indications

myelodysplastic syndrome

acute myeloid leukemia

Therapies

Midostaurin

Gilteritinib

Age Groups: adult | senior
Covered Countries FRA | ESP | DEU | BEL | AUT